Search research articles
Contact Us
Filters
Showing results (81-90 of 96) with videos related to
Page
of 10
Sort By:
European Urology Oncology
|
December 17, 2023
A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma
Pavlos Msaouel, Randy F Sweis, Manojkumar Bupathi, et al.
The New England Journal of Medicine
|
February 18, 2026
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer
Christof Vulsteke, Nabil Adra, Pongwut Danchaivijitr, et al.
JCO Precision Oncology
|
November 15, 2021
Differential Activity of PARP Inhibitors in <i>BRCA1</i>- Versus <i>BRCA2</i>-Altered Metastatic Castration-Resistant Prostate Cancer
Fadi Taza, Albert E Holler, Wei Fu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2023
Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer
Luca Antonelli, Davide Ardizzone, Isamu Tachibana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 17, 2024
SWOG/NCI Phase II Dual Anti-CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian Cancer
Young Kwang Chae, Megan Othus, Sandip Pravin Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 2024
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer
Tanya Dorff, Lisa G Horvath, Karen Autio, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 9, 2025
NCCN Guidelines® Insights: Testicular Cancer, Version 2.2025
Timothy Gilligan, Daniel W Lin, Nabil Adra, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 10, 2025
Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology
Daniel E Spratt, Sandy Srinivas, Nabil Adra, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 16, 2024
NCCN Guidelines® Insights: Prostate Cancer, Version 3.2024
Edward M Schaeffer, Sandy Srinivas, Nabil Adra, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 12, 2022
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023
Edward M Schaeffer, Sandy Srinivas, Nabil Adra, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 96) with videos related to
Sort By:
Page
of 10
European Urology Oncology
|
December 17, 2023
A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma
Pavlos Msaouel, Randy F Sweis, Manojkumar Bupathi, et al.
The New England Journal of Medicine
|
February 18, 2026
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer
Christof Vulsteke, Nabil Adra, Pongwut Danchaivijitr, et al.
JCO Precision Oncology
|
November 15, 2021
Differential Activity of PARP Inhibitors in <i>BRCA1</i>- Versus <i>BRCA2</i>-Altered Metastatic Castration-Resistant Prostate Cancer
Fadi Taza, Albert E Holler, Wei Fu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2023
Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer
Luca Antonelli, Davide Ardizzone, Isamu Tachibana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 17, 2024
SWOG/NCI Phase II Dual Anti-CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian Cancer
Young Kwang Chae, Megan Othus, Sandip Pravin Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 2024
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer
Tanya Dorff, Lisa G Horvath, Karen Autio, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 9, 2025
NCCN Guidelines® Insights: Testicular Cancer, Version 2.2025
Timothy Gilligan, Daniel W Lin, Nabil Adra, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 10, 2025
Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology
Daniel E Spratt, Sandy Srinivas, Nabil Adra, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 16, 2024
NCCN Guidelines® Insights: Prostate Cancer, Version 3.2024
Edward M Schaeffer, Sandy Srinivas, Nabil Adra, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 12, 2022
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023
Edward M Schaeffer, Sandy Srinivas, Nabil Adra, et al.
Page
of 10